Marina Biotech (MRNA) Enters Agreement to Acquire Turing Pharma's Intranasal Ketamine Program
Tweet Send to a Friend
Marina Biotech, Inc. (OTC: MRNA) and Turing Pharmaceuticals AG a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE